US Stock MarketDetailed Quotes

Aktis Oncology (AKTS)

Watchlist
  • 29.440
  • -1.710-5.49%
Close Jun 26 16:00 ET
  • 29.440
  • -0.0010.00%
Post 20:01 ET
1.63BMarket Cap-24.27P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aktis Oncology (AKTS) Revenue Breakdown Overview

By Business/Source

Currency:USD
2026/Q1
Stock NameRevenueRatio
Research and development of targeted radiopharmaceuticals to treat a broad range of solid tumor3.23M100.00%

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
United States6.5M100.00%
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +32.29%
Sample Name
Sample Code
 +9.63%
Sample Name
Sample Code
 -5.77%
4
United States Gasoline Fund Lp
UGA
-6.70%
5
ProShares Ultra Energy
DIG
-9.96%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +6.23%
Sample Name
Sample Code
 +4.21%
Sample Name
Sample Code
 +3.94%
4
TAL Education
TAL
+3.16%
5
New Oriental
EDU
+2.93%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On the 23rd, U.S. President Trump stated that Iran had conceded and agreed to keep the Strait of Hormuz open, and claimed that Iran accepted Show More
The U.S. and Iran have agreed on a roadmap to reach a final deal within 60 days—I see an options trading window that hasn’t been fully priced in yet.
美伊和平曙光初現！全球市場「拆彈式狂歡」：誰在帶頭衝鋒，升势還能跑多遠？

- No more -